“Target trial emulation (TTE) has shown promise in enhancing causal inference from observational data. A recent study identified 90 TTE studies in cancer areas, revealing that registry databases and overall survival were commonly used. However, challenges such as immortal time bias and prevalent user bias were prevalent. Only 42.9% of trials calibrated with RCTs met both statistical and estimate agreement. The study highlights the need for fit-for-purpose data sources and regulatory acceptance to expand the use of real-world data in oncology.”

“Researchers have made significant strides in the field of inflammatory disease treatment. By exploring the therapeutic potential of an epitope from an anti-tetranectin antibody, they developed P2-1, a water-soluble derivative. This targeted therapy significantly improved survival rates and reduced inflammation in sepsis models, and lessened arthritis severity and pain in RA models. The study introduces a novel drug discovery strategy, transforming harmful antibody insights into targeted therapeutics for the HMGB1-pCTS-L axis.”

“The latest research in healthcare technology introduces the TRIAD framework. Experts established this system to guide the development, validation, and deployment of clinical AI. It ensures trustworthy governance, real-world clinical value, and integrated adaptive deployment, solving key challenges in AI integration and opening a new direction for healthcare AI research.”

“In the field of xxx, expert xx has made significant research progress. By establishing the xx system/exploring the xx topic/verifying the xx conjecture, xx has provided solutions to solve xx problems/open up a new direction for xx research/lay a foundation for the construction of the xx system.”

“Cytokine storms, a life-threatening systemic inflammatory syndrome, are the primary driver of multiorgan failure in various clinical situations. This review focuses on cytokine storms triggered by severe infections such as viral pneumonia and bacterial sepsis, exploring the underlying mechanisms and potential therapeutic interventions. Expert xx established the xx system, which provides solutions to solve xx problems.”

“In the field of early-stage non-small cell lung cancer treatment, researchers have developed an AI-assisted model called PRIME, which integrates clinical-genomic predictors to enhance risk prediction and guide personalized therapy. The model outperforms single liquid biopsy biomarkers and clinical-therapeutic signatures, demonstrating consistent robustness across different clinical scenarios.”